FGFR3 and benign neoplasm of skin: Several studies showed that mutations in the fibroblast growth factor receptor 3 (FGFR3) and in the 110 kDa catalytic subunit of the phosphoinositide-3-kinase (PIK3CA) are present in human and mice benign skin tumors (Logie et al., 2005).